Donaldson Company heads into its August 26 earnings report with options positioning turning sharply more defensive even as short sellers quietly step back.
The standout signal this week is in options. Put demand has surged to its most elevated level in months — the put/call ratio hit 0.43 on Tuesday, more than three standard deviations above its 20-day average of 0.34. That z-score of 3.3 is exceptional for a name this quiet, and it marks the most defensive options posture DCI has seen in recent memory, well above the prior range that had barely moved from the 0.31–0.34 band through most of July. The stock has slipped 3% on the week to $93.97, still up roughly 4% over the past month, but the options market is pricing in more two-way risk than usual ahead of next Wednesday's print.
Short interest, by contrast, tells a calmer story. Bears have been retreating — SI dropped 15% in a single session on August 18 to 3.0% of the free float, unwinding a brief spike that took it back toward 4.1% on August 17. The month-long trend is clearly lower, with shorts now about 12% smaller than four weeks ago. Borrowing costs are minimal at 0.39% and falling, down more than 20% on the week. Availability is extremely loose at over 1,600% — meaning roughly 70 million shares remain available to borrow against the 3.5 million currently short. There is no squeeze dynamic here. The options defensiveness looks like genuine earnings hedging rather than a signal that new short sellers are building positions.
The Street enters earnings with a modestly bullish tilt. Baird's Richard Eastman lifted his target to $105 this morning — the most recent and notable move — maintaining an Outperform while upgrading his price view from $95. That puts Baird above the consensus mean of $98.80, which sits roughly 5% above the current price. The direction of travel from analysts has been mixed over the past several months: multiple target cuts through February and March were followed by a Jefferies upgrade to Buy in January with a $120 target, though that looks stretched relative to where the stock has traded since. Morgan Stanley carries an Equal-Weight at $91, effectively flat to current levels. Valuation multiples have drifted lower — the P/E has compressed roughly 1.1 turns over the past 30 days to around 20.5x, and EV/EBITDA has similarly eased by about 1.2 turns to 13.9x. Both moves suggest the market has been gently de-rating the stock even as the price itself has held up. The EPS momentum factor score is a bright spot at 92nd percentile over 30 days and 81st over 90 days, indicating analyst estimate revisions have been running firmly positive even if the broader forward earnings growth rank (32nd percentile) is more muted. The dividend score ranks in the 99th percentile, reflecting Donaldson's long track record of consistent payouts, though the dividend history in this snapshot is stale and specific current yield figures should be verified separately.
The bull case rests on Life Sciences momentum — the segment grew 13.1% in fiscal 2025, anchored by Food & Beverage and Disk Drive strength — alongside aftermarket filtration revenues that tend to hold up through industrial softness. Bears point to Aerospace and Defense flattening after record levels, ongoing gross margin pressure from the post-COVID inflation cycle, and the cyclical exposure of Donaldson's core mobile end-markets: transportation, construction, mining, and agriculture, all of which face capital expenditure headwinds. Peers have been broadly weak this week — TWI fell 10%, CNH dropped 5.6%, and PCAR lost 3.4% — suggesting the industrial complex is under selling pressure broadly, which adds context to DCI's own 3% weekly decline.
The prior earnings print, in early June, produced a 4.2% single-day gain and a 5.3% five-day follow-through — a clean beat-and-rally sequence. Whether that pattern repeats will come down to how the Life Sciences and Industrial Solutions segments track against the more cautious margin and cycle guidance embedded in the current consensus, and whether management signals any shift in its Aerospace and Defense outlook for fiscal 2026.
See the live data behind this article on ORTEX.
Open DCI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
